4.6 Article

Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

Khe Hoang-Xuan et al.

Summary: The management of primary central nervous system lymphoma (PCNSL) is a controversial topic in neuro-oncology. The European Association of Neuro-Oncology (EANO) formed a multidisciplinary task force to update the evidence-based guidelines and include immunosuppressed patients. The guideline provides consensus considerations and recommendations for the treatment of PCNSL, including intraocular manifestations and specific management of the elderly.

NEURO-ONCOLOGY (2023)

Article Hematology

Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD

Marshall McKenna et al.

Summary: This retrospective analysis examined the use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post-transplant lymphoproliferative disorder (PTLD). The results showed that the safety and efficacy of CD19 CAR-T therapy in treating PTLD appeared similar to pivotal CAR-T data.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Multidisciplinary Sciences

Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats

Julia Su Zhou Li et al.

Summary: Epstein-Barr virus (EBV) is an oncogenic herpesvirus associated with various cancers. In this study, researchers found that the EBNA1 protein of EBV binds to a repetitive copy of an 18-base-pair imperfect palindromic sequence on human chromosome 11q23, leading to chromosome breakage. Increasing levels of EBNA1 binding trigger chromosome breakage and acquisition of structural variations in chromosome 11, which is associated with cancer development. The presence of EBV is also associated with chromosome rearrangements in various cancer types.

NATURE (2023)

Article Oncology

Molecular and clinical diversity in primary central nervous system lymphoma

I. Hernandez-Verdin et al.

Summary: Through comprehensive multi-omic analysis, we identified and characterized four molecular patterns in PCNSL, which have a distinct prognostic impact and can guide future clinical stratification and targeted interventions.

ANNALS OF ONCOLOGY (2023)

Review Hematology

Primary central nervous system lymphoma

Lauren R. Schaff et al.

Summary: Primary central nervous system lymphoma (PCNSL) is a rare malignancy that affects the brain, spinal cord, or eye. Early diagnosis and timely treatment are crucial for optimal outcomes. Advances in high-dose methotrexate chemotherapy have improved prognosis, but relapse is still common. Novel treatments targeting abnormal pathways show promise for relapsed/refractory PCNSL.
Review Oncology

The CD70-CD27 axis in oncology: the new kids on the block

Tal Flieswasser et al.

Summary: The CD70-CD27 axis has been found to play a role in tumor progression and immune suppression, while also participating in co-stimulation in immune responses under normal physiological conditions. In hematological malignancies, co-expression of CD70 and CD27 promotes the stemness, proliferation, and survival of cancer cells. In solid tumors, CD70 expression facilitates immune evasion through CD27 expression in the tumor microenvironment. The CD70-CD27 axis has emerged as a novel target for oncology research and (pre)clinical therapeutic strategies.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Hematology

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Matthew J. Frigault et al.

Summary: This study conducted a clinical trial of tisagenlecleucel in highly refractory patients with primary central nervous system lymphoma (PCNSL). The results showed that most patients responded well to the treatment and there were no severe side effects. This suggests that tisagenlecleucel is safe and effective in this patient population.
Article Multidisciplinary Sciences

The genomic and transcriptional landscape of primary central nervous system lymphoma

Josefine Radke et al.

Summary: This study profiles the genomic and transcriptomic landscape of primary lymphomas of the central nervous system (PCNSL) and identifies common mutations in immune pathways and upregulated TERT gene expression. It also reveals distinct pathway differences between PCNSL and other primary CNS lymphomas, as well as DLBCL.

NATURE COMMUNICATIONS (2022)

Article Oncology

Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation

Antonio Sorrentino et al.

Summary: This study reveals a molecular mechanism that protects tumor cells from cytotoxic T-cell attack and demonstrates the feasibility of pharmacological inhibition of this pathway.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Review Rheumatology

Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases

Alice Tison et al.

Summary: Immune-checkpoint inhibitors (ICIs) have changed the management of advanced cancers and have shown promising efficacy. However, they can also cause immune-related adverse events (irAEs), which pose safety risks. The use of ICIs in patients with pre-existing autoimmune disease is an area of increasing interest, and there is accumulating evidence suggesting acceptable safety profile in this population. Balancing immune suppression and anti-tumor immune response remains a challenge in clinical practice.

NATURE REVIEWS RHEUMATOLOGY (2022)

Article Oncology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019

Quinn T. Ostrom et al.

Summary: The report provides the latest data on primary brain tumors in the United States, including incidence rates, mortality rates, and relative survival rates. The overall incidence rate is higher in females and non-Hispanic population, and glioblastoma is the most common malignant brain tumor, while meningioma is the most common non-malignant brain tumor. The relative survival rate is lower for malignant brain tumors and higher for non-malignant brain tumors.

NEURO-ONCOLOGY (2022)

Article Multidisciplinary Sciences

Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape

Maurizio Mangolini et al.

Summary: Mutations in NOTCH1 and NOTCH2 contribute to immune escape of malignant B cells by up-regulating PD-L1 and silencing the HLA-II locus, possibly affecting the effectiveness of immune therapies.

NATURE COMMUNICATIONS (2022)

Article Immunology

STING regulates BCR signaling in normal and malignant B cells

Chih-Hang Anthony Tang et al.

Summary: STING plays a role in negatively regulating BCR signaling in B cells, leading to reduced response to BCR activation; both expression level and deficiency of STING can impact B cell function and antigen response.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Hematology

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

M. K. Gandhi et al.

Summary: Primary central nervous system lymphoma (PCNSL) is a rare brain lymphoma that has distinct immunobiological differences between EBV-associated PCNSL in immunosuppressed individuals and EBV-negative PCNSL. These differences are evident in cellular mutations and immune environments.
Article Hematology

Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors

Vignesh Shanmugam et al.

Summary: Notch receptors play a crucial role in B-cell lymphomas, with mutations in NOTCH1 or NOTCH2 affecting NICD stability. NOTCH2 activation is mainly seen in low-grade B-cell neoplasms, particularly in SMZL, while NOTCH1 mutations are common in DLBCL. These findings suggest different roles for NOTCH1 and NOTCH2 in B-cell lymphoma pathogenesis.

BLOOD ADVANCES (2021)

Article Biochemical Research Methods

VIRUSBreakend: Viral Integration Recognition Using Single Breakends

Daniel L. Cameron et al.

Summary: VIRUSBreakend is a high-speed tool that can identify viral DNA presence and genomic integration with high sensitivity and nearly zero false discovery rate, detecting viral integrations anywhere in the host genome.

BIOINFORMATICS (2021)

Article Hematology

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

Tim Sauer et al.

Summary: CD70 is a promising target antigen for AML treatment, and CD70-CAR T cells demonstrate good proliferation and antitumor activity in vitro and in vivo for CD70-positive AML patients, showing potential as a new treatment strategy.
Letter Clinical Neurology

Primary CNS lymphoma after CLIPPERS: a case series

Sofia Doubrovinskaia et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Hematology

EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features

Jennifer R. Chapman et al.

Summary: In the era of cART, approximately half of HIV-DLBCL are EBV-related. HIV-DLBCL are enriched for MYC rearrangements and mutations, and lack BCL2 rearrangements regardless of EBV status. EBV-negative and EBV-positive HIV-DLBCL show important genetic and clinical differences, with the former having more mutations and higher mutation frequency for genes like TP53, SGK1, and EP300, while the latter occur in lower CD4 count, non-GCB origin, and recurrent STAT3 mutations.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Oncology

Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing

Niklas Gebauer et al.

Summary: This study combined multiple genome sequencing techniques to characterize the genomic features of EBV-positive DLBCL (NOS) tumors, identified unique mutations, and predicted effects on the NFκB pathway and WNT signaling. This comprehensive description supports the evidence of the pathobiological independence of this rare disease entity and aids in stratifying the molecular taxonomy of aggressive lymphomas for future therapeutic strategies.

BLOOD CANCER JOURNAL (2021)

Article Multidisciplinary Sciences

Pan-cancer analysis of whole genomes

Peter J. Campbell et al.

NATURE (2020)

Article Multidisciplinary Sciences

The repertoire of mutational signatures in human cancer

Ludmil B. Alexandrov et al.

NATURE (2020)

Article Multidisciplinary Sciences

Early-onset autoimmunity associated with SOCS1 haploinsufficiency

Jerome Hadjadj et al.

NATURE COMMUNICATIONS (2020)

Article Biotechnology & Applied Microbiology

Determining cell type abundance and expression from bulk tissues with digital cytometry

Aaron M. Newman et al.

NATURE BIOTECHNOLOGY (2019)

Review Genetics & Heredity

DNA sensing by the cGAS-STING pathway in health and disease

Mona Motwani et al.

NATURE REVIEWS GENETICS (2019)

Review Biochemistry & Molecular Biology

STING: a master regulator in the cancer-immunity cycle

Yuanyuan Zhu et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

GENCODE reference annotation for the human and mouse genomes

Adam Frankish et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biotechnology & Applied Microbiology

Improved metagenomic analysis with Kraken 2

Derrick E. Wood et al.

GENOME BIOLOGY (2019)

Article Multidisciplinary Sciences

The molecular basis of JAK/STAT inhibition by SOCS1

Nicholas P. D. Liau et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

Anupama Reddy et al.

Review Immunology

Mechanisms and consequences of Jak-STAT signaling in the immune system

Alejandro V. Villarino et al.

NATURE IMMUNOLOGY (2017)

Article Clinical Neurology

Genomic characterization of primary central nervous system lymphoma

Kazutaka Fukumura et al.

ACTA NEUROPATHOLOGICA (2016)

Article Biochemical Research Methods

CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing

Eric Talevich et al.

PLOS COMPUTATIONAL BIOLOGY (2016)

Article Biochemical Research Methods

Sambamba: fast processing of NGS alignment formats

Artem Tarasov et al.

BIOINFORMATICS (2015)

Article Multidisciplinary Sciences

A global reference for human genetic variation

David M. Altshuler et al.

NATURE (2015)

Review Biotechnology & Applied Microbiology

Therapeutic modulation of Notch signalling - are we there yet?

Emma R. Andersson et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Multidisciplinary Sciences

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov et al.

NATURE (2013)

Article Biotechnology & Applied Microbiology

Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing

Joke Reumers et al.

NATURE BIOTECHNOLOGY (2012)

Article Medicine, General & Internal

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srdan Verstovsek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Biochemistry & Molecular Biology

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Kai Wang et al.

NUCLEIC ACIDS RESEARCH (2010)

Article Biochemical Research Methods

The Sequence Alignment/Map format and SAMtools

Heng Li et al.

BIOINFORMATICS (2009)

Article Biochemical Research Methods

Fast and accurate short read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2009)

Article Multidisciplinary Sciences

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

AP Weng et al.

SCIENCE (2004)